Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Center Phase II Study of 5-Fluorouracil/ Folinic Acid Plus Gemcitabine in Patients With Advanced Pancreatic Cancer.

NCT00919282 is registered in ClinicalTrials.gov with CONKO-Studiengruppe as lead sponsor.

NCT NCT00919282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00919282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Center Phase II Study of 5-Fluorouracil/ Folinic Acid Plus Gemcitabine in Patients With Advanced Pancreatic Cancer.
Lead sponsor
CONKO-Studiengruppe
Phase
Phase 2
Overall status
Completed
Start date
September 30, 1997
Completion date
December 31, 2002
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic cancer